Plus Therapeutics Historical PE Ratio image   This PSTV PE ratio history page last updated 10/17/2023
Plus Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2023
8/14/2023
2.50-0.59-2.36NA
Q1 2023
4/20/2023
4.65-2.10-8.40NA
Q4 2022
2/23/2023
5.85-2.40-9.60NA
Q3 2022
10/20/2022
7.20-2.85-11.40NA
Q2 2022
7/21/2022
7.65-3.60-14.40NA
Q1 2022
4/21/2022
13.20-2.85-11.40NA
Q4 2021
2/24/2022
15.15-4.05-16.20NA
Q3 2021
10/21/2021
25.95-4.20-16.80NA
Q2 2021
7/22/2021
34.20-3.75-15.00NA
Q1 2021
4/22/2021
33.60-4.95-19.80NA
Q4 2020
2/22/2021
56.25-11.10-44.40NA
Q3 2020
10/22/2020
41.40-5.85-23.40NA
Q2 2020
8/10/2020
44.85-6.75-27.00NA
Q1 2020
5/14/2020
31.95-4.20-16.80NA
Q4 2019
3/30/2020
34.059.9039.600.9
Q3 2019
11/14/2019
35.85-0.45-1.80NA
Q2 2019
8/15/2019
58.20-76.80-307.20NA
Q1 2019
5/14/2019
195.00-0.18-0.72NA
Q4 2018
3/29/2019
195.000.110.44443.2
Q3 2018
11/14/2018
255.00-0.45-1.80NA
Q2 2018
8/14/2018
300.00-0.59-2.36NA
Q1 2018
5/10/2018
240.00-0.07-0.28NA
Q4 2017
3/8/2018
240.00-0.10-0.40NA
Q3 2017
11/9/2017
300.00-0.14-0.56NA
Q2 2017
8/10/2017
262.50-0.19-0.76NA
Q1 2017
5/11/2017
705.00-0.26-1.04NA
Q4 2016
3/23/2017
1230.00-0.24-0.96NA
Q3 2016
11/9/2016
1290.00-0.26-1.04NA
Q2 2016
8/4/2016
1635.00-0.43-1.72NA
Q1 2016
5/10/2016
202.50-0.03-0.12NA
Q4 2015
3/3/2016
157.50-0.03-0.12NA
Q3 2015
11/5/2015
285.00-0.04-0.16NA
Q2 2015
8/6/2015
307.50-0.06-0.24NA
Q1 2015
5/11/2015
532.50-0.07-0.28NA
Q4 2014
3/12/2015
862.50-0.08-0.32NA
Q3 2014
11/6/2014
375.00-0.12-0.48NA
Q2 2014
8/11/2014
1267.50-0.15-0.60NA
Q1 2014
5/12/2014
1867.50-0.14-0.56NA
Q4 2013
3/11/2014
2302.50-0.14-0.56NA
Q3 2013
11/7/2013
2085.00-0.08-0.32NA
Q2 2013
8/8/2013
1987.500.050.20>500
Q1 2013
5/9/2013
1942.50-0.11-0.44NA
Q4 2012
3/7/2013
2197.50-0.55-2.20NA
Q3 2012
11/8/2012
2415.00-0.19-0.76NA
Q2 2012
8/8/2012
1822.50-0.13-0.52NA
Plus Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q2 2023
8/14/2023
2.50-0.59-7.94NA
Q1 2023
4/20/2023
4.65-2.10-10.95NA
Q4 2022
2/23/2023
5.85-2.40-11.70NA
Q3 2022
10/20/2022
7.20-2.85-13.35NA
Q2 2022
7/21/2022
7.65-3.60-14.70NA
Q1 2022
4/21/2022
13.20-2.85-14.85NA
Q4 2021
2/24/2022
15.15-4.05-16.95NA
Q3 2021
10/21/2021
25.95-4.20-24.00NA
Q2 2021
7/22/2021
34.20-3.75-25.65NA
Q1 2021
4/22/2021
33.60-4.95-28.65NA
Q4 2020
2/22/2021
56.25-11.10-27.90NA
Q3 2020
10/22/2020
41.40-5.85-6.90NA
Q2 2020
8/10/2020
44.85-6.75-1.50NA
Q1 2020
5/14/2020
31.95-4.20-71.55NA
Q4 2019
3/30/2020
34.059.90-67.53NA
Q3 2019
11/14/2019
35.85-0.45-77.32NA
Q2 2019
8/15/2019
58.20-76.80-77.32NA
Q1 2019
5/14/2019
195.00-0.18-1.11NA
Q4 2018
3/29/2019
195.000.11-1.00NA
Q3 2018
11/14/2018
255.00-0.45-1.21NA
Q2 2018
8/14/2018
300.00-0.59-0.90NA
Q1 2018
5/10/2018
240.00-0.07-0.50NA
Q4 2017
3/8/2018
240.00-0.10-0.69NA
Q3 2017
11/9/2017
300.00-0.14-0.83NA
Q2 2017
8/10/2017
262.50-0.19-0.95NA
Q1 2017
5/11/2017
705.00-0.26-1.19NA
Q4 2016
3/23/2017
1230.00-0.24-0.96NA
Q3 2016
11/9/2016
1290.00-0.26-0.75NA
Q2 2016
8/4/2016
1635.00-0.43-0.53NA
Q1 2016
5/10/2016
202.50-0.03-0.16NA
Q4 2015
3/3/2016
157.50-0.03-0.20NA
Q3 2015
11/5/2015
285.00-0.04-0.25NA
Q2 2015
8/6/2015
307.50-0.06-0.33NA
Q1 2015
5/11/2015
532.50-0.07-0.42NA
Q4 2014
3/12/2015
862.50-0.08-0.49NA
Q3 2014
11/6/2014
375.00-0.12-0.55NA
Q2 2014
8/11/2014
1267.50-0.15-0.51NA
Q1 2014
5/12/2014
1867.50-0.14-0.31NA
Q4 2013
3/11/2014
2302.50-0.14-0.28NA
Q3 2013
11/7/2013
2085.00-0.08-0.69NA
Q2 2013
8/8/2013
1987.500.05-0.80NA
Q1 2013
5/9/2013
1942.50-0.11-0.98NA
Q4 2012
3/7/2013
2197.50-0.55NANA
Q3 2012
11/8/2012
2415.00-0.19NANA
Q2 2012
8/8/2012
1822.50-0.13NANA
Quotes delayed 20 minutes

Email EnvelopeFree PSTV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Plus Therapeutics (PSTV) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PSTX PE Ratio History
PTCT PE Ratio History
PTE PE Ratio History
PTGX PE Ratio History
PTIX PE Ratio History
PTPI PE Ratio History
PULM PE Ratio History
PYXS PE Ratio History
QDEL PE Ratio History
QLGN PE Ratio History
How should the PSTV historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Plus Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PSTV Historical PE Ratio page.

What is the average historical PE for PSTV based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PSTV historical PE ratio using the annualized quarterly earnings method works out to 222.1.

What is the average historical PE for PSTV based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PSTV historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Plus Therapeutics Historical PE Ratio information for Plus Therapeutics' stock. The average PSTV historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 222.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PSTV historical PE based on this TTM earnings result method is NA. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PSTV historical PE result, against the recent PE: when this page was posted on 10/16/2023, the most recent closing price for PSTV had been 1.23, and the most recent quarterly earnings result, annualized, was 39.6. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent PSTV PE on 10/16/2023 based on annualized quarterly EPS was 0.0. Based on PSTV's history, that recent PE is low relative to the historical average, with the recent PE 100.0% lower than the historical average PE across our data set for Plus Therapeutics.

For self directed investors doing their due diligence on PSTV or any other given stock, valuation analysis for PSTV can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Plus Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PSTV. Thanks for visiting, and the next time you need to research PSTV Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of PSMG, Top Ten Hedge Funds Holding ANY, Leveraged Global ETFs.

 

Plus Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.1%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.1%.